Revenue Growth Across Operations
Total revenues increased 9.6% YoY from $4.10B to $4.50B in Q1 FY2026, reflecting continued demand for healthcare services and capacity utilization improvements across UHS facilities.
UNIVERSAL HEALTH SERVICES INC 已通过 8-K 新闻稿公布 Q2 2026 业绩，10-Q 提交后将自动生成完整 AI 解读。
上一期分析暂无中文版，相关内容以英文显示。
2026年第二季度，净营收同比增长8.3%至$4.638 billion，归属于UHS的净利润增至$358.4 million，即每股摊薄收益$5.98。
营收
46.38亿美元
每股收益 (non-GAAP)
5.98美元
业绩指引
对于2026年全年，UHS将净营收指引修订为$18.501 billion至$18.762 billion，并将调整后每股摊薄收益指引修订为$22.28至$23.65。
来源：SEC Form 8-K（Item 2.02），EX-99.1 press release。数字为公司自报，预期值来自 Finnhub 分析师一致预期。这是当日快照——完整 AI 解读（管理层讨论、风险、审计意见）将在 10-Q/10-K 提交后自动生成。
想第一时间拿到完整解读？ 关注 UNIVERSAL HEALTH SERVICES INC，完整报告生成后我们会通知你。
摘自 Q1 2026 10-Q 中的管理层讨论：
Total revenues increased 9.6% YoY from $4.10B to $4.50B in Q1 FY2026, reflecting continued demand for healthcare services and capacity utilization improvements across UHS facilities.
Operating income grew 10.6% YoY to $502.9M, with operating margin modestly improving from 11.09% to 11.19%, indicating disciplined cost management relative to revenue growth.
Diluted EPS surged 17.7% YoY from $4.80 to $5.65, outpacing net income growth of 10.1%, suggesting that share buybacks ($163.8M in Q1 FY2026) meaningfully reduced the share count and amplified per-share earnings.
Revenue
44.95亿美元
+9.65% 同比
EPS (Diluted)
5.65美元
+17.71% 同比
Operating Income
5.03亿美元
+10.56% 同比
将 UHS 加入关注列表，10-Q 提交后几分钟内即可在邮箱收到 AI 解读。